Neuralink, the brain-computer interface startup led by Elon Musk, has achieved another milestone as the U.S. Food and Drug Administration (FDA) gave a green light for the company to implant its brain chip in a second person as soon as next month, the Wall Street Journal first reported today (May 20). The regulatory clearance follows Neuralink’s first human trial in January, which experienced malfunction post-implantation, but the company has proposed solutions to the issues in the next test.
Thank you for signing up!
By clicking submit, you agree to our terms of service and acknowledge we may use your information to send you emails, product samples, and promotions on this website and other properties. You can opt out anytime.
In January, Noland Arbaugh, a 30-year-old quadriplegic who had no movement below his shoulders for eight years following a spinal cord injury, underwent surgery to have Neuralink’s N1 implant installed beneath his skull. The........